We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
-7.32%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$124M
AUM Growth
-$20.9M
(-14%)
Cap. Flow
-$2.47M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RPTX
Repare Therapeutics
RPTX
|
+$1.66M |
| 2 |
Entrada Therapeutics
TRDA
|
+$810K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM
MPM Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, MPM Asset Management held 6 positions worth $124M, down 14% from $145M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 0%. MPM Asset Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- MPM Asset Management's biggest Q4 2024 reduction was Repare Therapeutics, cutting an estimated $1.66M.
- MPM Asset Management's ten largest holdings make up 100% of its $124M portfolio in Q4 2024.
- MPM Asset Management opened 0 new positions and closed 0 in Q4 2024.
- MPM Asset Management's portfolio value fell 14% quarter-over-quarter to $124M.
Based on MPM Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.